Carrum Health extended the reach of its bundled cancer care through an alliance with City of Hope, one of the largest cancer research and treatment organizations in the United States. First launched on the East Coast last year, Carrum Health is now offering its fixed price comprehensive bundle for first-time, non-metastatic breast cancer treatment, including a two-year warranty on care, at City of Hope facilities throughout Southern California. This includes more than 35 convenient locations including its newly opened City of Hope Orange County Lennar Foundation Cancer Center.
“Cancer treatments haven’t historically been included in bundled payments because of their length of treatment and complexity of cases. But we know that they are top of mind for self-insured employers trying to tackle rising healthcare costs and access the best quality of care for their employees,” said Sach Jain, CEO and founder of Carrum Health. “Carrum Health eases these concerns with the only value-based bundled payment programs for oncology. Since launching the industry’s first comprehensive cancer care bundle last year, we’ve seen great demand from employers looking to offer their employees access to top cancer specialists closer to home. We are proud to work with City of Hope to make this a reality.”
With Carrum Health’s bundled cancer care package patients with non-metastatic breast cancer may be eligible to receive up to two years of treatment at City of Hope, including excision surgery, chemotherapy, radiation therapy, care for treatment-related complications, and interdisciplinary check-ins and follow-ups.
Healthcare startup Abridge has inked a deal with nonprofit health plan Priority Health. As part of the deal, Priority Health includes Abridge in its list of supplemental benefits for all Individual Medicare Advantage and Dual Eligible Special Needs Plan members to help them follow through on their care plans. Abridge uses AI to structure and summarize information from spoken conversations.
“We want to make it easier for our members to take action in their personal health journey by providing the necessary tools and resources,” said Scott Norman, vice president of Medicare at Priority Health. “Abridge is a vital component of our programs designed to keep members healthy. Our partnership will support our longstanding commitment to bring our members innovative benefits that will help drive better individual health outcomes.”
To red more, click here.
Strive Heath, which developed a kidney care support framework using an integrated care delivery system to support the patient journey from chronic kidney disease to end-stage kidney disease, has agreed to a collaboration with Southern California Kidney Consultants (SCKC).
As part of the deal, Strive and SCKC share in the financial benefits, management and governance of risk contracts with Medicare and Medicare Advantage plans and Independent Physician Associations (IPAs), with the goal of improving outcomes and reducing costs, according to a press release.
Strive made a similar deal earlier this year with Nephrology Associates of Northern Illinois and Indiana (NANI).
To read more, click here.
Concerto Biosciences, a biotech developing microbial communities that restore deficient microbiomes to treat disease,has raised $23 million in a Series A round led by Safar Partners and with participation from Horizons Ventures and M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany).
The funding will be used to advance its first product through first-in-human studies, accelerate the discovery platform, and leverage the platform to expand its line of products in partnership with other companies, according to a press release.
To read more, click here.
